Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Anastasov

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Voenno-Meditsinskii Zhurnal|June 22, 2000
[Diagnosis and the technology for optimizing the medical support of a troop unit]N G Korshever, S V Polkovov, O V Lavrinenko, et al.
Leukemia|August 8, 2008
Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2M Klier, N Anastasov, A Hermann, et al.
Scientific Reports|February 8, 2017
The Rb1 tumour suppressor gene modifies telomeric chromatin architecture by regulating TERRA expressionI Gonzalez-Vasconcellos, R Schneider, N Anastasov, et al.
British Journal of Cancer|October 17, 2013
MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasionN Falkenberg, N Anastasov, K Rappl, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Voenno-Meditsinskii Zhurnal|June 22, 2000
[Diagnosis and the technology for optimizing the medical support of a troop unit]N G Korshever, S V Polkovov, O V Lavrinenko, et al.
Leukemia|August 8, 2008
Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2M Klier, N Anastasov, A Hermann, et al.
Scientific Reports|February 8, 2017
The Rb1 tumour suppressor gene modifies telomeric chromatin architecture by regulating TERRA expressionI Gonzalez-Vasconcellos, R Schneider, N Anastasov, et al.
British Journal of Cancer|October 17, 2013
MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasionN Falkenberg, N Anastasov, K Rappl, et al.
Pageof 1